Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/75952
Campo DC Valoridioma
dc.contributor.authorZander, Tobiasen_US
dc.contributor.authorBaldi, Sebastianen_US
dc.contributor.authorRabellino, Martinen_US
dc.contributor.authorKirsch, Daviden_US
dc.contributor.authorLlorens, Rafaelen_US
dc.contributor.authorZerolo, Ignacioen_US
dc.contributor.authorQian, Zhongen_US
dc.contributor.authorMaynar Moliner, Manuelen_US
dc.date.accessioned2020-11-25T11:43:28Z-
dc.date.available2020-11-25T11:43:28Z-
dc.date.issued2009en_US
dc.identifier.issn0174-1551en_US
dc.identifier.otherWoS-
dc.identifier.urihttp://hdl.handle.net/10553/75952-
dc.description.abstractThe aim of this study was to evaluate the effectiveness of endovascular repair in the treatment of isolated iliac artery aneurysm (IAA) using Excluder bifurcated endograft. Eight consecutive patients with IAA were treated during a period of 45 months using Excluder bifurcated endograft. Two patients presented with isolated IAA rupture and were treated emergently, whereas the other six patients underwent elective treatment. All aneurysms lacked sufficient proximal necks and therefore were not suitable for tubular-shaped endograft. Follow-up imaging was performed at 1 week, at every 3 months during the first year, semiannually until 2 years, and annually afterward using angio-computed axial tomography and plain films. Technical success was achieved in all patients. No mortality was seen despite two patients having IAA rupture. Follow-up (12 to 60 months) was done in all but one patient. During this period, complications were observed in three patients. One patient developed sexual impotence at 3-month follow up; one patient presented unilateral gluteal claudication after the procedure, which resolved at 3 months; and one patient developed a graft porosity-related endoleak, which was successfully managed with placement of an additional ipsilateral iliac extension. Endovascular treatment of isolated IAA using bifurcated endograft is safe and can be an alternative to surgical treatment. The benefits from decreased morbidity and mortality of endoluminal treatment of isolated IAA using bifurcated endograft outweigh the minor complications associated with this technique, which are mostly related to occlusion of hypogastric arteries.en_US
dc.languageengen_US
dc.relation.ispartofCardioVascular and Interventional Radiologyen_US
dc.sourceCardiovascular And Interventional Radiology [ISSN 0174-1551], v. 32 (5), p. 928-936, (Septiembre 2009)en_US
dc.subject32 Ciencias médicasen_US
dc.subject.otherAbdominal Aortic-Aneurysmsen_US
dc.subject.otherEndovascular Repairen_US
dc.subject.otherExperienceen_US
dc.subject.otherManagementen_US
dc.subject.otherEndoprosthesisen_US
dc.subject.otherComplicationsen_US
dc.subject.otherInterruptionen_US
dc.subject.otherAortographyen_US
dc.subject.otherEtiologyen_US
dc.subject.otherUpdateen_US
dc.subject.otherInterventional Radiologyen_US
dc.subject.otherBifurcated Endograften_US
dc.subject.otherIsolated Iliac Aneurysmen_US
dc.subject.otherEndoprosthesisen_US
dc.subject.otherEndovascularen_US
dc.titleBifurcated Endograft (Excluder) in the Treatment of Isolated Iliac Artery Aneurysm: Preliminary Reporten_US
dc.typeinfo:eu-repo/semantics/Articleen_US
dc.typeArticleen_US
dc.identifier.doi10.1007/s00270-009-9551-5en_US
dc.identifier.scopus69949128609-
dc.identifier.isi000269838400009-
dc.contributor.authorscopusid24537953400-
dc.contributor.authorscopusid19933359400-
dc.contributor.authorscopusid24537604700-
dc.contributor.authorscopusid7005339268-
dc.contributor.authorscopusid7006542164-
dc.contributor.authorscopusid16641392900-
dc.contributor.authorscopusid57195594774-
dc.contributor.authorscopusid7005962555-
dc.description.lastpage936en_US
dc.identifier.issue5-
dc.description.firstpage928en_US
dc.relation.volume32en_US
dc.investigacionCiencias de la Saluden_US
dc.type2Artículoen_US
dc.contributor.daisngid94228-
dc.contributor.daisngid1496829-
dc.contributor.daisngid1236857-
dc.contributor.daisngid3874821-
dc.contributor.daisngid28135379-
dc.contributor.daisngid3875761-
dc.contributor.daisngid20984622-
dc.contributor.daisngid30319800-
dc.description.numberofpages9en_US
dc.utils.revisionen_US
dc.contributor.wosstandardWOS:Zander, T-
dc.contributor.wosstandardWOS:Baldi, S-
dc.contributor.wosstandardWOS:Rabellino, M-
dc.contributor.wosstandardWOS:Kirsch, D-
dc.contributor.wosstandardWOS:Llorens, R-
dc.contributor.wosstandardWOS:Zerolo, I-
dc.contributor.wosstandardWOS:Qian, Z-
dc.contributor.wosstandardWOS:Maynar, M-
dc.date.coverdateSeptiembre 2009en_US
dc.identifier.ulpgcen_US
dc.contributor.buulpgcBU-MEDen_US
dc.description.jcr1,949
dc.description.jcrqQ2
dc.description.scieSCIE
item.grantfulltextnone-
item.fulltextSin texto completo-
crisitem.author.deptGIR IUIBS: Tecnología Médica y Audiovisual-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.orcid0000-0001-9154-0712-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.fullNameMaynar Moliner,Manuel-
Colección:Artículos
Vista resumida

Citas SCOPUSTM   

8
actualizado el 21-jul-2024

Citas de WEB OF SCIENCETM
Citations

6
actualizado el 21-jul-2024

Visitas

95
actualizado el 27-ene-2024

Google ScholarTM

Verifica

Altmetric


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.